Will Singleterry

Company: LUMICKS

Job title: Commercial Director, Immuno-Oncology

Seminars:

Cellular Avidity to Tumor Cells is a Key Driver for Engineered T Cell Functioning 11:10 am

– CARs and TCRs do not need highest affinity for best T cell performance – CAR T cells require suboptimal cellular avidity while TCR T cells function best having the highest cellular avidity – First CAR T cell studies reveal correlation between avidity data and in vivo tumor reduction and T cell function – Cellular…Read more

day: Day One